{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:49:33Z","timestamp":1787197773860,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1245\/s10434-019-07814-w","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T22:14:04Z","timestamp":1569536044000},"page":"736-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Tyrer\u2013Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS"],"prefix":"10.1245","volume":"27","author":[{"given":"Monica G.","family":"Valero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashely","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"issue":"10","key":"7814_CR1","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","volume":"20","author":"PR Portschy","year":"2013","unstructured":"Portschy PR, Marmor S, Nzara R, Virnig BA, Tuttle TM. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis. Ann Surg Oncol. 2013;20(10):3240\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"7814_CR2","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, et al. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33(33):3945\u201352.","journal-title":"J Clin Oncol"},{"issue":"12","key":"7814_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/aje\/152.12.1154","volume":"152","author":"H Anderson","year":"2000","unstructured":"Anderson H, Bladstrom A, Olsson H, Moller TR. Familial breast and ovarian cancer: a Swedish population-based register study. Am J Epidemiol. 2000;152(12):1154\u201363.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"7814_CR4","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004;23(7):1111\u201330.","journal-title":"Stat Med"},{"issue":"11","key":"7814_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"E Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003;40(11):807\u201314.","journal-title":"J Med Genet"},{"issue":"22","key":"7814_CR6","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1200\/JCO.2010.28.0784","volume":"28","author":"JC Boughey","year":"2010","unstructured":"Boughey JC, Hartmann LC, Anderson SS, et al. Evaluation of the Tyrer\u2013Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol. 2010;28(22):3591\u20136.","journal-title":"J Clin Oncol"},{"issue":"2","key":"7814_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10549-013-2725-5","volume":"142","author":"TA King","year":"2013","unstructured":"King TA, Muhsen S, Patil S, et al. Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat. 2013;142(2):445\u201353.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"7814_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41416-018-0120-z","volume":"119","author":"LL Lo","year":"2018","unstructured":"Lo LL, Milne RL, Liao Y, Cuzick J, Terry MB, Phillips KA. Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ. Br J Cancer. 2018;119(1):36\u20139.","journal-title":"Br J Cancer"},{"issue":"6","key":"7814_CR9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/cncr.22136","volume":"107","author":"LC Collins","year":"2006","unstructured":"Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses\u2019 Health Study. Cancer. 2006;107(6):1240\u20137.","journal-title":"Cancer"},{"issue":"19","key":"7814_CR10","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","volume":"25","author":"AC Degnim","year":"2007","unstructured":"Degnim AC, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25(19):2671\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"7814_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13058-015-0653-5","volume":"17","author":"AR Brentnall","year":"2015","unstructured":"Brentnall AR, Harkness EF, Astley SM, et al. Mammographic density adds accuracy to both the Tyrer\u2013Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res. 2015;17(1):147.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"7814_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s13058-014-0451-5","volume":"16","author":"J Warwick","year":"2014","unstructured":"Warwick J, Birke H, Stone J, et al. Mammographic breast density refines Tyrer\u2013Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res. 2014;16(5):451.","journal-title":"Breast Cancer Res"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07814-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07814-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07814-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T23:05:12Z","timestamp":1600988712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07814-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["7814"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07814-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"assertion":[{"value":"15 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Tari A. King has received honoraria as a speaker for Genomic Health. All other authors have no conflicts of interest to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}